Vicarious Surgical Inc.
NYSE:RBOT
12 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.854 | 1.94 | 0.316 | 0 | 0 |
| Gross Profit
| -1.854 | -1.94 | -0.316 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 47.578 | 43.9 | 22.1 | 9.796 | 7.479 |
| General & Administrative Expenses
| 26.858 | 29.715 | 13.498 | 2.328 | 2.054 |
| Selling & Marketing Expenses
| 6.23 | 6.463 | 2.976 | 0.861 | 0.25 |
| SG&A
| 33.088 | 36.178 | 16.474 | 3.189 | 2.304 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 80.666 | 80.078 | 38.574 | 12.985 | 9.783 |
| Operating Income
| -80.666 | -80.078 | -38.574 | -12.985 | -9.783 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 9.595 | 85.235 | 3.016 | 0.11 | 0.469 |
| Income Before Tax
| -71.071 | 5.157 | -7.268 | -12.875 | -9.314 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -84 | -0.227 | 0.003 | -0.068 |
| Net Income
| -71.071 | 89.157 | -7.041 | -12.878 | -9.314 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -14.7 | 20.77 | -2.19 | -4.91 | -1.7 |
| EPS Diluted
| -14.6 | 20.99 | -2.19 | -4.91 | -1.7 |
| EBITDA
| -69.192 | 7.297 | -34.802 | -0.161 | -9.679 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |